Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3769993011 | Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3769994017 | Doxycycline monohydrate 100 mg orodispersible tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only doxycycline in oromucosal dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Doxycycline monohydrate | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Orodispersible tablet | false | Inferred relationship | Some | ||
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 100 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance (attribute) | Doxycycline monohydrate | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Plays role | Antimalarial therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)